Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications

Area of Science:

• Hepatology
• Virology
• Internal Medicine

Background:

• Chronic hepatitis B (CHB) poses a significant risk for liver complications.
• Identifying risk factors is essential for effective CHB management and treatment strategies.

Purpose of the Study:

• To identify risk factors associated with the development of complications in Asian patients with CHB.
• To understand the long-term progression and outcomes of CHB in a large cohort.

Main Methods:

• A cohort of 3233 Chinese CHB patients was followed for a mean of 46.8 months.
• Data collected included liver biochemistry, viral markers, HBV DNA levels, and clinical outcomes like acute exacerbations, HBeAg seroconversion, cirrhosis, and hepatocellular carcinoma.
• Statistical analysis was performed to determine independent risk factors for complications and survival.

Main Results:

• Elevated alanine aminotransferase (ALT) levels between 0.5-2 times the upper limit of normal (ULN) were linked to an increased risk of complications.
• Male sex, signs of chronic liver disease, older age, low albumin, and high alpha-fetoprotein levels were independently associated with a higher cumulative risk of complications.
• Male sex, hepatitis symptoms, older age, low albumin, and existing complications predicted shorter survival.

Conclusions:

• Prolonged low-level viremia, indicated by sustained ALT levels of 0.5-2x ULN, is a primary driver of insidious liver damage and subsequent complications in Asian CHB patients.
• These findings highlight the importance of monitoring liver enzyme levels for predicting long-term outcomes in CHB.